NCT02614456View on ClinicalTrials.gov

Combination of Interferon-gamma and Nivolumab for Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

December 11, 2015

Primary Completion Date

June 12, 2019

Study Completion Date

June 12, 2019

Conditions
Advanced Solid Tumors
Interventions
DRUG

interferon-gamma and nivolumab

Trial Locations (1)

19111

Fox Chase Cancer Center, Philadelphia

All Listed Sponsors
collaborator

Horizon Pharma Ireland, Ltd., Dublin Ireland

INDUSTRY

lead

Fox Chase Cancer Center

OTHER

NCT02614456 - Combination of Interferon-gamma and Nivolumab for Advanced Solid Tumors | Biotech Hunter | Biotech Hunter